Global Pharmaceuticals Mergers and Acquisitions Deals in Q1 2022: Key Themes Driving Notable Deals –

DUBLIN–(BUSINESS WIRE)–The “Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q1 2022 – Thematic Research” report has been added to’s offering.

The report analyzes the disruptive themes that have driven M&A activity in Q1 2022 in the Pharma Sector

The pharma sector recorded 188 deals accounting for a value of $18 billion in Q1 2022, a marginal increase in deal volume from 181 deals in the previous quarter.


  • The report provides an overview of merger and acquisition activity globally in Q1 2022 in Pharma Sector

  • It identifies the themes driving most notable to deals announced in Q1 2022 in the Pharma Sector

Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A)

The report lists down the most notable deals in Pharma sector to make it easy for clients to get a view of themes disrupting the sector and prepare for the future

Key topics covered:

  • Global M&A deals in Q1 2022 – Key takeaways

  • Review of global M&A deals in Q1 2022

  • Themes driving global M&A deals in Q1 2022

  • Appendices

For more information about this report visit

Source: GlobalData

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Comments are closed.